🇺🇸 FDA
Pipeline program

SSGJ-709

SSGJ-709-101

Phase 1 small_molecule active

Quick answer

SSGJ-709 for Advanced Malignant Tumors is a Phase 1 program (small_molecule) at Sunshine Biopharma with 1 ClinicalTrials.gov record(s).

Program details

Company
Sunshine Biopharma
Indication
Advanced Malignant Tumors
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials